News

Luna Labs’ MedSim Product Lines Acquired by Integrated Medcraft

Integrated MedCraft LLC today announced it has acquired the TrueClot and Dislotech product lines from Luna Labs. This announcement is more than a successful transaction. It is an example of innovation being accelerated with the right strategic partner.

We built Luna Labs with a clear mission to incubate, accelerate, and grow technologies to the point where they are poised to achieve their full potential. This acquisition demonstrates that our strategy is working as intended.

What started as an SBIR project to create a realistic blood simulant for the Department of Defense has evolved into TrueClot Bleeding Control Training Products. Routinely used to train professional first responders, law enforcement, and combat medics, the market opportunity is bigger than our company can address alone. This acquisition ensures these products will reach the scale and impact they deserve.

Dislotech Joint Reduction Trainers are also ready for growth, offering athletic trainers and medical professionals the opportunity for hands-on joint reduction training prior to practice on patients.

“I am proud of what our Luna Labs’ MedSim team has accomplished,” said Michael Danilich, PhD, Sr. VP of Operations at Luna Labs, and Principal Investigator, TrueClot. “We didn’t just create products, we created new training standards. It’s been rewarding to watch TrueClot grow from a concept to a suite of tools trusted around the world – that’s the kind of impact we strive to achieve.”

This evolution required relentless determination from our development, operations, sales, marketing, and manufacturing teams. They built the most realistic bleeding control and joint reduction training tools available, and their work set a new benchmark for emergency responder training. Congratulations to Brad Day, Kevin Tate, Joe Cattell-Gordon, Ron Wenzel, Keyanna Grayson, Dana Rich, Lianne Landers, Kelley Virgilio, Matt Patterson, Christopher Tison, PhD, MBA, and many others who contributed to this success.

The transition will be seamless with operations, personnel, and manufacturing staying in Charlottesville. TrueClot and Dislotech products will be sold as part of Integrated Medcraft’s full product portfolio and available to emergency response training markets worldwide.

 

Read more here.

Recent News

10/29/2026

ReAlta Life Sciences Launches KnowHIE, a New Online Educational Resource for Families of Babies Diagnosed with Hypoxic Ischemic Encephalopathy (HIE)

ReAlta Life Sciences Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company focused on safely targeting neutrophils and central components of the complement system to potentially revolutionize the treatment of inflammatory disorders, today announced the launch of KnowHIE.com, a new educational website designed to help families and caregivers better understand neonatal hypoxic ischemic encephalopathy (HIE) …

10/28/2026

Adial Pharmaceuticals Announces Name Change to Azora Therapeutics and New Executive Team, Focused on Advancing AT177, an Oral, Colon-Targeted AhR Agonist for Ulcerative Colitis

Adial Pharmaceuticals, Inc. (NASDAQ: ADIL), a biopharmaceutical company developing treatments for serious inflammatory diseases, today announced that it has changed its corporate name to Azora Therapeutics, Inc. The company’s common stock is expected to commence trading on The Nasdaq Capital Market under the new ticker symbol “AZR” on October 29, 2026. Azora has also launched …

10/28/2026

U.S. Bioscience Industry Powers Over $3 Trillion in Economic Output, New Report Finds

Today, the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations (CSBA) released new national and state-level data on the U.S. bioscience industry’s economic impact. The report, “The U.S. Bioscience Economy: Advancing Innovation and Strengthening States and Regions,” examines the industry’s economic footprint through employment, wages, business establishments, university research and development, access …